July 07, 2020
Emphasizing that she found no fraud in vote-handling or counts prior to confirmation of antibiotic developer Melinta Therapeutics' Chapter 11 reorganization in April, a bankruptcy judge in Delaware declined Tuesday to reconsider a recent denial of stockholder requests to revoke the plan.
April 03, 2020
A Delaware bankruptcy judge ruled Friday that the exculpation provisions in the Chapter 11 plan of antibiotic maker Melinta Therapeutics only apply until the court-approved plan becomes effective, limiting the length of the provision that was requested by the debtor.
April 02, 2020
Bankrupt antibiotic developer Melinta Therapeutics received court approval Thursday in Delaware for its proposed Chapter 11 debt-for-equity transaction that will see a secured creditor acquire the reorganized company in exchange for $140 million in debt relief.
March 30, 2020
The U.S. Trustee's Office is arguing to a Delaware bankruptcy judge that the legal liability releases in antibiotics maker Melinta Therapeutics Inc.'s proposed Chapter 11 "far exceed" what is allowed under Delaware case law.
March 13, 2020
A restructuring support agreement that forms the basis of the Chapter 11 plan of pharmaceutical company Melinta Therapeutics Inc. received court approval Friday in Delaware bankruptcy court, paving the way for consensual confirmation of the plan next month.
February 21, 2020
Antibiotics maker Melinta Therapeutics Inc. received court approval Friday in Delaware for its Chapter 11 plan disclosure statement after the debtor agreed to add new information regarding its intent to substantively consolidate its estates for distribution purposes.
February 14, 2020
Bankrupt antibiotics maker Melinta Therapeutics Inc. received two objections Friday to its proposed Chapter 11 plan that seeks to substantively consolidate its various entities' debts for distributions to creditors, a move derided by a significant creditor and the U.S. trustee as unjustified.
February 10, 2020
Ailing antibiotics developer Melinta Therapeutics Inc. appears to have secured approval for a previously contested Chapter 11 sale plan that allows top creditor Deerfield Management Co. to serve as the opening bidder with a $140 million credit bid at an upcoming auction.